Biocon Ltd Q4FY25; 106% rise in Profits

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Financial Results:

Biocon Ltd reported Revenues for Q4FY25 of ₹4,417.00 Crores up from ₹3,917.00 Crore year on year, a rise of 12.76%.

Total Expenses for Q4FY25 of ₹3,987.00 Crores up from ₹3,638.00 Crores year on year, a rise of 9.59%.

Consolidated Net Profit of ₹459.00 Crores up 105.83% from ₹223.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹2.87, up 153.98% from ₹1.13 in the same quarter of the previous year.